New device aims to speed recovery after artery procedures
NCT ID NCT07279220
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new medical device designed to stop bleeding from the femoral artery after a catheter procedure. About 238 adults will be randomly assigned to receive either the new device or an existing one. The goal is to see if the new device is safe and effective, and whether it helps patients get out of bed and go home sooner.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Vascular closure device (a medical device used to seal the puncture site in the femoral artery after a catheter procedure)
What this could lead to
If successful, this could provide a safer and more effective way to stop bleeding after femoral artery procedures, potentially reducing recovery time and hospital stays.
What could go wrong
This is an early-stage trial with only 238 participants, so results may not apply to all patients. The device may not work better than existing options, and there is a risk of bleeding or other complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOSTASIS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital of Army Medical University (PLA)
Chongqing, 400037, China